Epigenetic enzymes are the therapeutic targets for CD4+CD25+/highFoxp3+ regulatory T cells

Translational Research

Volumn 165, Issue 1, 2015, Pages 221-240

  Lopez Pastrana, Jahaira ^a   Shao, Ying ^a   Chernaya, Valeria ^a   Wang, Hong ^a   Yang, Xiao Feng ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDESLEUKIN; CD4 ANTIGEN; DNA METHYLTRANSFERASE INHIBITOR; ENTINOSTAT; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 2 RECEPTOR ALPHA; MICRORNA 155; TRANSCRIPTION FACTOR FOXP3; UNTRANSLATED RNA; VORINOSTAT; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; HISTONE; IL2RA PROTEIN, HUMAN;

AMINO ACID SEQUENCE; AUTOIMMUNE DISEASE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL THERAPY; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE STRUCTURE; GRAFT VERSUS HOST REACTION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; INFLAMMATORY DISEASE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NEOPLASM; NONHUMAN; NUCLEOTIDE SEQUENCE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; REVIEW; ANIMAL; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; MOUSE; TRANSLATIONAL RESEARCH;

ANIMALS; CLINICAL TRIALS AS TOPIC; DNA METHYLATION; EPIGENESIS, GENETIC; FORKHEAD TRANSCRIPTION FACTORS; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; PERIPHERAL TOLERANCE; RNA, UNTRANSLATED; T-LYMPHOCYTES, REGULATORY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84919686339     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.08.001     Document Type: Review

References (191)

1. S. Sakaguchi, R. Setoguchi, H. Yagi, and T. Nomura Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease Curr Top Microbiol Immunol 305 2006 51 66
2. L.W. Collison, G.M. Delgoffe, and C.S. Guy The composition and signaling of the IL-35 receptor are unconventional Nat Immunol 13 2012 290 299
3. X. Li, J. Mai, and A. Virtue IL-35 is a novel responsive anti-inflammatory cytokine - a new system of categorizing anti-inflammatory cytokines PLoS One 7 2012 e33628
4. H. Katoh, P. Zheng, and Y. Liu FOXP3: genetic and epigenetic implications for autoimmunity J Autoimmun 41 2013 72 78
5. G. Lal, N. Zhang, and W. van der Touw Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation J Immunol 182 2009 259 273
6. X.F. Yang, P. Fang, and S. Meng The FOX transcription factors regulate vascular pathology, diabetes and Tregs Front Biosci (Schol Ed) 1 2009 420 436
7. M.L. Bettini, F. Pan, and M. Bettini Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency Immunity 36 2012 717 730
8. L.T. Jeker, H. Bour-Jordan, and J.A. Bluestone Breakdown in peripheral tolerance in type 1 diabetes in mice and humans Cold Spring Harb Perspect Med 2 2012 a007807
9. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057 1061
10. J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat Immunol 4 2003 330 336
11. G. Vahedi, A.C. Poholek, and T.W. Hand Helper T-cell identity and evolution of differential transcriptomes and epigenomes Immunol Rev 252 2013 24 40
12. G. Lal, and J.S. Bromberg Epigenetic mechanisms of regulation of Foxp3 expression Blood 114 2009 3727 3735
13. Z. Xiong, J. Song, and Y. Yan Higher expression of Bax in regulatory T cells increases vascular inflammation Front Biosci 13 2008 7143 7155
14. Z. Xiong, Y. Yan, and J. Song Expression of TCTP antisense in CD25(high) regulatory T cells aggravates cuff-injured vascular inflammation Atherosclerosis 203 2009 401 408
15. Y. Yan, Z. Xiong, and S. Zhang CD25high T cells with a prolonged survival inhibit development of diabetes Int J Immunopathol Pharmacol 21 2008 767 780
16. J. Mai, H. Wang, and X.F. Yang Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity Front Biosci (Landmark Ed) 15 2010 986 1006
17. X.F. Yang Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets Front Biosci 13 2008 1472 1499
18. X.F. Yang, P. Fang, and S. Meng The forkhead transcription factors play important roles in vascular pathology and immunology Adv Exp Med Biol 665 2009 90 105
19. J.L. Pastrana, X. Sha, and A. Virtue Regulatory T cells and atherosclerosis J Clin Exp Cardiol 2012 suppl 12 2012 2
20. R.K. Gershon, and K. Kondo Cell interactions in the induction of tolerance: the role of thymic lymphocytes Immunology 18 1970 723 737
21. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
22. C.L. Bennett, J. Christie, and F. Ramsdell The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nat Genet 27 2001 20 21
23. F. Simonetta, A. Chiali, and C. Cordier Increased CD127 expression on activated FOXP3+ CD4+ regulatory T cells Eur J Immunol 40 2010 2528 2538
24. J. Liu, A. Lluis, and S. Illi T regulatory cells in cord blood - FOXP3 demethylation as reliable quantitative marker PLoS One 5 2010 e13267
25. J. Chen, Q. Luo, and Y. Yuan Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion Mol Cell Biol 30 2010 5621 5635
26. G. Wieczorek, A. Asemissen, and F. Model Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue Cancer Res 69 2009 599 608
27. Y. Kitagawa, N. Ohkura, and S. Sakaguchi Molecular determinants of regulatory T cell development: the essential roles of epigenetic changes Front Immunol 4 2013 106
28. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono Regulatory T cells and immune tolerance Cell 133 2008 775 787
29. D.F. Ketelhuth, and G.K. Hansson Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall Thromb Haemost 106 2011 779 786
30. C.G. Fathman, and N.B. Lineberry Molecular mechanisms of CD4+ T-cell anergy Nat Rev Immunol 7 2007 599 609
31. S. Sakaguchi, M. Ono, and R. Setoguchi Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease Immunol Rev 212 2006 8 27
32. G.L. Stephens, and E.M. Shevach Foxp3+ regulatory T cells: selfishness under scrutiny Immunity 27 2007 417 419
33. R. Tordjman, Y. Lepelletier, and V. Lemarchandel A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response Nat Immunol 3 2002 477 482
34. M. Yadav, C. Louvet, and D. Davini Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo J Exp Med 209 2012 1713 1722 S1-S19
35. J.M. Weiss, A.M. Bilate, and M. Gobert Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells J Exp Med 209 2012 1723 1742 S1
36. S. Sakaguchi Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 2004 531 562
37. H. Ait-Oufella, B.L. Salomon, and S. Potteaux Natural regulatory T cells control the development of atherosclerosis in mice Nat Med 12 2006 178 180
38. N. Sasaki, T. Yamashita, M. Takeda, and K. Hirata Regulatory T cells in atherogenesis J Atheroscler Thromb 19 2012 503 515
39. H. Jonuleit, and E. Schmitt The regulatory T cell family: distinct subsets and their interrelations J Immunol 171 2003 6323 6327
40. K.L. Hippen, J.L. Riley, C.H. June, and B.R. Blazar Clinical perspectives for regulatory T cells in transplantation tolerance Semin Immunol 23 2011 462 468
41. H. Groux Type 1 T-regulatory cells: their role in the control of immune responses Transplantation 75 9 suppl 2003 8S 12S
42. M.G. Roncarolo, M.K. Levings, and C. Traversari Differentiation of T regulatory cells by immature dendritic cells J Exp Med 193 2001 F5 F9
43. Y. Chen, Q. Chen, G. Lu, Z. Fan, and S. Zhong The autocrine regulatory effect of vasoactive intestinal peptide on the growth of human pancreatic carcinoma cells Chin Med Sci J 9 1994 215 219
44. D.R. Littman, and A.Y. Rudensky Th17 and regulatory T cells in mediating and restraining inflammation Cell 140 2010 845 858
45. M.E. Brunkow, E.W. Jeffery, and K.A. Hjerrild Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse Nat Genet 27 2001 68 73
46. S.F. Ziegler FOXP3: of mice and men Annu Rev Immunol 24 2006 209 226
47. Y. Wu, M. Borde, and V. Heissmeyer FOXP3 controls regulatory T cell function through cooperation with NFAT Cell 126 2006 375 387
48. S. Floess, J. Freyer, and C. Siewert Epigenetic control of the foxp3 locus in regulatory T cells PLoS Biol 5 2007 e38
49. D. Rudra, P. deRoos, and A. Chaudhry Transcription factor Foxp3 and its protein partners form a complex regulatory network Nat Immunol 13 2012 1010 1019
50. A. Marson, K. Kretschmer, and G.M. Frampton Foxp3 occupancy and regulation of key target genes during T-cell stimulation Nature 445 2007 931 935
51. Y. Zheng Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells Nature 445 2007 936 940
52. R.M. Samstein Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification Cell 151 2012 153 166
53. W. Fu A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells Nat Immunol 13 2012 972 980
54. A. Dvir, J.W. Conaway, and R.C. Conaway Mechanism of transcription initiation and promoter escape by RNA polymerase II Curr Opin Genet Dev 11 2001 209 214
55. A. Portela, and M. Esteller Epigenetic modifications and human disease Nat Biotechnol 28 2010 1057 1068
56. C.H. Arrowsmith Epigenetic protein families: a new frontier for drug discovery Nat Rev Drug Discov 11 2012 384 400
57. M. Ehrlich Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells Nucleic Acids Res 10 1982 2709 2721
58. A. Bird DNA methylation patterns and epigenetic memory Genes Dev 16 2002 6 21
59. C.B. Wilson, E. Rowell, and M. Sekimata Epigenetic control of T-helper-cell differentiation Nat Rev Immunol 9 2009 91 105
60. M.S. Jamaluddin, X. Yang, and H. Wang Hyperhomocysteinemia, DNA methylation and vascular disease Clin Chem Lab Med 45 2007 1660 1666
61. L. Wang Foxp3+ T-regulatory cells require DNA methyltransferase 1 expression to prevent development of lethal autoimmunity Blood 121 2013 3631 3639
62. J. Lan DNA methyltransferases and methyl-binding proteins of mammals Acta Biochim Biophys Sin (Shanghai) 42 2010 243 252
63. X.J. He, T. Chen, and J.K. Zhu Regulation and function of DNA methylation in plants and animals Cell Res 21 2011 442 465
64. S.C. Wu, and Y. Zhang Active DNA demethylation: many roads lead to Rome Nat Rev Mol Cell Biol 11 2010 607 620
65. R.M. Kohli, and Y. Zhang TET enzymes, TDG and the dynamics of DNA demethylation Nature 502 2013 472 479
66. J.P. Thomson CpG islands influence chromatin structure via the CpG-binding protein Cfp1 Nature 464 2010 1082 1086
67. J.R. Dobosy, and E.U. Selker Emerging connections between DNA methylation and histone acetylation Cell Mol Life Sci 58 2001 721 727
68. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705
69. O.J. Rando, and H.Y. Chang Genome-wide views of chromatin structure Annu Rev Biochem 78 2009 245 271
70. J.A. Latham, and S.Y. Dent Cross-regulation of histone modifications Nat Struct Mol Biol 14 2007 1017 1024
71. M.S. Cosgrove, J.D. Boeke, and C. Wolberger Regulated nucleosome mobility and the histone code Nat Struct Mol Biol 11 2004 1037 1043
72. N.J. Krogan Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is linked to transcriptional elongation by RNA polymerase II Mol Cell Biol 23 2003 4207 4218
73. H.H. Ng Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity Mol Cell 11 2003 709 719
74. H. Santos-Rosa Active genes are tri-methylated at K4 of histone H3 Nature 419 2002 407 411
75. B.E. Bernstein Methylation of histone H3 Lys 4 in coding regions of active genes Proc Natl Acad Sci U S A 99 2002 8695 8700
76. G. Vidali, E.L. Gershey, and V.G. Allfrey Chemical studies of histone acetylation. The distribution of epsilon-N-acetyllysine in calf thymus histones J Biol Chem 243 1968 6361 6366
77. V.G. Allfrey, R. Faulkner, and A.E. Mirsky Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis Proc Natl Acad Sci U S A 51 1964 786 794
78. B.M. Turner Cellular memory and the histone code Cell 111 2002 285 291
79. B.D. Strahl, and C.D. Allis The language of covalent histone modifications Nature 403 2000 41 45
80. X.J. Yang The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases Nucleic Acids Res 32 2004 959 976
81. J.M. Sun Phosphorylated serine 28 of histone H3 is associated with destabilized nucleosomes in transcribed chromatin Nucleic Acids Res 35 2007 6640 6647
82. A. Ciechanover Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting Cell Death Differ 12 2005 1178 1190
83. P.M. Voorhees, and R.Z. Orlowski The proteasome and proteasome inhibitors in cancer therapy Annu Rev Pharmacol Toxicol 46 2006 189 213
84. J.C. Tanny Ubiquitylation of histone H2B controls RNA polymerase II transcription elongation independently of histone H3 methylation Genes Dev 21 2007 835 847
85. Y. Shiio, and R.N. Eisenman Histone sumoylation is associated with transcriptional repression Proc Natl Acad Sci U S A 100 2003 13225 13230
86. S. Messner, and M.O. Hottiger Histone ADP-ribosylation in DNA repair, replication and transcription Trends Cell Biol 21 2011 534 542
87. M. Esteller Non-coding RNAs in human disease Nat Rev Genet 12 2011 861 874
88. K.M. Schmitz Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes Genes Dev 24 2010 2264 2269
89. P.P. Lee A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival Immunity 15 2001 763 774
90. A. Toker Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus J Immunol 190 2013 3180 3188
91. J.K. Polansky Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells J Mol Med (Berl) 88 2010 1029 1040
92. E. Zorn IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo Blood 108 2006 1571 1579
93. U. Baron DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells Eur J Immunol 37 2007 2378 2389
94. J.K. Polansky DNA methylation controls Foxp3 gene expression Eur J Immunol 38 2008 1654 1663
95. H.P. Kim, and W.J. Leonard CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation J Exp Med 204 2007 1543 1551
96. Y. Zheng Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate Nature 463 2010 808 812
97. L. Wu, and Q. Zheng Active demethylation of the IL-2 promoter in CD4+ T cells is mediated by an inducible DNA glycosylase, Myh Mol Immunol 58 2014 38 49
98. S. Dominitzki Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells J Immunol 179 2007 2041 2045
99. A. Samanta TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3 Proc Natl Acad Sci U S A 105 2008 14023 14027
100. A. Doganci Pathological role of IL-6 in the experimental allergic bronchial asthma in mice Clin Rev Allergy Immunol 28 2005 257 270
101. M. Tang Stat 3 signal transduction pathway correlates with proliferation of vascular smooth muscle cells of rats Zhonghua Xin Xue Guan Bing Za Zhi 33 2005 832 835
102. Y. Xiao Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function Curr Opin Immunol 22 2010 583 591
103. J. van Loosdregt Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization Blood 115 2010 965 974
104. B. Li, and M.I. Greene FOXP3 actively represses transcription by recruiting the HAT/HDAC complex Cell Cycle 6 2007 1432 1436
105. B. Li FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression Proc Natl Acad Sci U S A 104 2007 4571 4576
106. Y. Liu Inhibition of p300 impairs Foxp3(+) T regulatory cell function and promotes antitumor immunity Nat Med 19 2013 1173 1177
107. J. van Loosdregt Rapid temporal control of Foxp3 protein degradation by sirtuin-1 PLoS One 6 2011 e19047
108. T. Akimova Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs Clin Immunol 136 2010 348 363
109. R. Tao Histone deacetylase inhibitors and transplantation Curr Opin Immunol 19 2007 589 595
110. U.H. Beier Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms Sci Signal 5 2012 ra45
111. M. Parra Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation J Biol Chem 280 2005 13762 13770
112. F. Dequiedt Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis J Exp Med 201 2005 793 804
113. C.L. Zhang, T.A. McKinsey, and E.N. Olson Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation Mol Cell Biol 22 2002 7302 7312
114. C.L. Zhang Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy Cell 110 2002 479 488
115. J. Zhang The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice J Clin Invest 119 2009 3048 3058
116. U.H. Beier Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival Mol Cell Biol 31 2011 1022 1029
117. F. Lan, A.C. Nottke, and Y. Shi Mechanisms involved in the regulation of histone lysine demethylases Curr Opin Cell Biol 20 2008 316 325
118. S. He The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease Blood 122 2013 4119 4128
119. Y. Tian Global mapping of H3K4me1 and H3K4me3 reveals the chromatin state-based cell type-specific gene regulation in human Treg cells PLoS One 6 2011 e27770
120. H. He Histone methylation mediates plasticity of human FOXP3(+) regulatory T cells by modulating signature gene expressions Immunology 141 2014 362 376
121. F. Antignano Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation J Clin Invest 124 2014 1945 1955
122. L. Wang Mbd2 promotes foxp3 demethylation and T-regulatory-cell function Mol Cell Biol 33 2013 4106 4115
123. B.S. Cobb T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer J Exp Med 201 2005 1367 1373
124. S.A. Muljo Aberrant T cell differentiation in the absence of Dicer J Exp Med 202 2005 261 269
125. A. Liston Dicer-dependent microRNA pathway safeguards regulatory T cell function J Exp Med 205 2008 1993 2004
126. X. Zhou Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity J Exp Med 205 2008 1983 1991
127. B.E. Clurman, and W.S. Hayward Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events Mol Cell Biol 9 1989 2657 2664
128. P.S. Eis, W. Tam, and L. Sun Accumulation of miR-155 and BIC RNA in human B cell lymphomas Proc Natl Acad Sci U S A 102 2005 3627 3632
129. A. Rodriguez, E. Vigorito, and S. Clare Requirement of bic/microRNA-155 for normal immune function Science 316 2007 608 611
130. T.H. Thai, D.P. Calado, and S. Casola Regulation of the germinal center response by microRNA-155 Science 316 2007 604 608
131. H.F. Stahl miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression PLoS One 4 2009 e7158
132. S. Kohlhaas Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells J Immunol 182 2009 2578 2582
133. L.F. Lu Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein Immunity 30 2009 80 91
134. R. Yao MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1 PLoS One 7 2012 e46082
135. Y. Zhan SOCS1 negatively regulates the production of Foxp3+ CD4+ T cells in the thymus Immunol Cell Biol 87 2009 473 480
136. L. Wei, A. Laurence, and J.J. O'Shea New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation Semin Cell Dev Biol 19 2008 394 400
137. L.A. Turka, and P.T. Walsh IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells Front Biosci 13 2008 1440 1446
138. L.O. Flowers, P.S. Subramaniam, and H.M. Johnson A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells Oncogene 24 2005 2114 2120
139. L.D. Jager The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis J Neuroimmunol 232 2011 108 118
140. C.R. Yu, R.R. Mahdi, and H.M. Oh Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation Invest Ophthalmol Vis Sci 52 2011 6978 6986
141. T. Chen, Z. Huang, and L. Wang MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages Cardiovasc Res 83 2009 131 139
142. M.M. Donners, I.M. Wolfs, and L.J. Stoger Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice PLoS One 7 2012 e35877
143. F.W. Miller, L. Alfredsson, and K.H. Costenbader Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop J Autoimmun 39 2012 259 271
144. F.W. Miller, K.M. Pollard, and C.G. Parks Criteria for environmentally associated autoimmune diseases J Autoimmun 39 2012 253 258
145. O. Ngalamika, Y. Zhang, H. Yin, M. Zhao, M.E. Gershwin, and Q. Lu Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review J Autoimmun 39 2012 451 465
146. C. Selmi, P.S. Leung, and D.H. Sherr Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop J Autoimmun 39 2012 272 284
147. C. Selmi, Q. Lu, and M.C. Humble Heritability versus the role of the environment in autoimmunity J Autoimmun 39 2012 249 252
148. B.M. Javierre, H. Hernando, and E. Ballestar Environmental triggers and epigenetic deregulation in autoimmune disease Discov Med 12 2011 535 545
149. A.C. Jenke, and M. Zilbauer Epigenetics in inflammatory bowel disease Curr Opin Gastroenterol 28 2012 577 584
150. R.M. O'Connell, D. Kahn, and W.S. Gibson MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development Immunity 33 2010 607 619
151. S. Costinean, N. Zanesi, and Y. Pekarsky Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice Proc Natl Acad Sci U S A 103 2006 7024 7029
152. Z.X. Chen, and A.D. Riggs DNA methylation and demethylation in mammals J Biol Chem 286 2011 18347 18353
153. Q. Zheng, Y. Xu, and Y. Liu Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice J Mol Med (Berl) 87 2009 1191 1205
154. J. Choi, J. Ritchey, and J.L. Prior In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia Blood 116 2010 129 139
155. J.P. Issa Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: dose, duration, and patient selection Nat Clin Pract Oncol 2 suppl 1 2005 S24 S29
156. C. Bronner Control of DNMT1 abundance in epigenetic inheritance by acetylation, ubiquitylation, and the histone code Sci Signal 4 2011 pe3
157. P.O. Esteve, Y. Chang, and M. Samaranayake A methylation and phosphorylation switch between an adjacent lysine and serine determines human DNMT1 stability Nat Struct Mol Biol 18 2011 42 48
158. S. He, J. Wang, and K. Kato Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells Blood 119 2012 1274 1282
159. Z. Mallat, A. Gojova, and V. Brun Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice Circulation 108 2003 1232 1237
160. A. Mor, D. Planer, and G. Luboshits Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis Arterioscler Thromb Vasc Biol 27 2007 893 900
161. L. Jia, L. Zhu, and J.Z. Wang Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease Atherosclerosis 228 2013 346 352
162. R. Castro, I. Rivera, and E.A. Struys Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease Clin Chem 49 2003 1292 1296
163. M.D. Jamaluddin, I. Chen, and F. Yang Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene Blood 110 2007 3648 3655
164. A. Mor, G. Luboshits, D. Planer, G. Keren, and J. George Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes Eur Heart J 27 2006 2530 2537
165. Z. Zhao, Y. Wu, and M. Cheng Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome Atherosclerosis 217 2011 518 524
166. O.J. de Boer, J.J. van der Meer, P. Teeling, C.M. van der Loos, and A.C. van der Wal Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions PLoS One 2 2007 e779
167. S. Patel, S.H. Chung, G. White, S. Bao, and D.S. Celermajer The "atheroprotective" mediators apolipoprotein A-I and Foxp3 are over-abundant in unstable carotid plaques Int J Cardiol 145 2010 183 187
168. E. Ammirati, D. Cianflone, and M. Banfi Circulating CD4+CD25hiCD127lo regulatory T-cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis Arterioscler Thromb Vasc Biol 30 2010 1832 1841
169. C.X. Lu, R.D. Xu, and M. Cao FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome Atherosclerosis 229 2013 263 270
170. P. Reddy, Y. Maeda, and K. Hotary Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect Proc Natl Acad Sci U S A 101 2004 3921 3926
171. O. Kepp, L. Galluzzi, and G. Kroemer Immune effectors required for the therapeutic activity of vorinostat Oncoimmunology 2 2013 e27157
172. B.S. Mann, J.R. Johnson, M.H. Cohen, R. Justice, and R. Pazdur FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma Oncologist 12 2007 1247 1252
173. D.J. Straus, M. Duvic, T. Kuzel, and S. Horwitz Results of a phase II trial of oral bexarotene (targretin) combined with interferon alfa-2b (intron-A) for patients with cutaneous T-cell lymphoma Cancer 109 2007 1799 1803
174. M. Duvic, M.L. Sherman, and G.S. Wood A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides J Am Acad Dermatol 55 2006 807 813
175. J. Vojinovic, N. Damjanov, and C. D'Urzo Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis Arthritis Rheum 63 2011 1452 1458
176. R. Tao, E.F. de Zoeten, and E. Ozkaynak Deacetylase inhibition promotes the generation and function of regulatory T cells Nat Med 13 2007 1299 1307
177. C. Donas, M. Fritz, and V. Manriquez Trichostatin A promotes the generation and suppressive functions of regulatory T cells Clin Dev Immunol 2013 2013 679804
178. N. Mishra, C.M. Reilly, D.R. Brown, P. Ruiz, and G.S. Gilkeson Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse J Clin Invest 111 2003 539 552
179. A.M. Grabiec, O. Korchynskyi, P.P. Tak, and K.A. Reedquist Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay Ann Rheum Dis 71 2012 424 431
180. K.M. Pauley, M. Satoh, A.L. Chan, M.R. Bubb, W.H. Reeves, and E.K. Chan Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients Arthritis Res Ther 10 2008 R101
181. H. Jonuleit, E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop, and A.H. Enk Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood J Exp Med 193 2001 1285 1294
182. S. Read, and F. Powrie CD4(+) regulatory T cells Curr Opin Immunol 13 2001 644 649
183. J. Yokokawa, V. Cereda, and C. Remondo Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer Clin Cancer Res 14 2008 1032 1040
184. U.K. Liyanage, T.T. Moore, and H.G. Joo Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma J Immunol 169 2002 2756 2761
185. J. Dannull, Z. Su, and D. Rizzieri Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells J Clin Invest 115 2005 3623 3633
186. H. Zhang, K.S. Chua, and M. Guimond Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells Nat Med 11 2005 1238 1243
187. J.S. Abrams, A.A. Rayner, and P.H. Wiernik High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinoma J Natl Cancer Inst 82 1990 1202 1206
188. S. Negrier, B. Escudier, and C. Lasset Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d'Immunotherapie N Engl J Med 338 1998 1272 1278
189. B. Barnett, I. Kryczek, P. Cheng, W. Zou, and T.J. Curiel Regulatory T cells in ovarian cancer: biology and therapeutic potential Am J Reprod Immunol 54 2005 369 377
190. L. Shen, M. Ciesielski, and S. Ramakrishnan Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models PLoS One 7 2012 e30815
191. L. Shen, and R. Pili Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy Oncoimmunology 1 2012 948 950